Plenary Discussion. The Eurasian Pharma Market: The Industry's View on Challenges and Prospects
EAEU Pharma Market: Growth, Barriers, Prospects
Production Localization: Incentives, Challenges, Success Stories
The Impact of Regulatory Requirements on Business Strategies
Liberalization of Public Procurement: New Opportunities for Business
Moderator: VYACHESLAV LOKSHIN
President, Association of International Pharmaceutical Manufacturers in the Republic of Kazakhstan
LARISA MATVEEVA
Executive Director Association of International Pharmaceutical Manufacturers
ALEXANDER BYKOV
Director of Healthcare Economics, R-Pharm
ELENA LEE
Founder, Dolce
ADILET NAZARBAYEV
General Director, Johnson & Johnson Kazakhstan
SVETLANA KIL
Chief Executive Director, Nobel Almaty Pharmaceutical Factory
10:30 – 11:00
10:30 – 11:00
Coffee Break & Networking
11:00 – 12:20
11:00 – 12:20
Plenary Session. State and Business: Creating Conditions for Industry Development
Legislative Changes: New Registration Rules, GMP Inspections, Clinical Trials
Harmonization of Requirements in the EAEU: Progress and Next Steps
Support for Localization and Innovation: Government Incentive Measures
Plans for Improving the Investment Climate in the Pharmaceutical Industry
Medicine Supply in CIS Countries: Discussion of the Model Law
RASHAD MAHMUDOV
Deputy Chairman of the Health Committee, Milli Majlis of the Republic of Azerbaijan
VADIM KUKAVA
Executive Director, Association of Pharmaceutical Companies "Pharmaceutical Innovations" ("InPharma")
MUHABBAT ASQAROVA
CEO, Association of Representatives of Foreign Pharmaceutical Companies and Manufacturers in Uzbekistan
NURLIBEK ASYLBEKOV
Chairman of the Management Board, SK-Pharmacy
MARAT KALIYEV
International Expert, State Medical Insurance Fund of the Republic of Uzbekistan
12:20 – 13:00
12:20 – 13:00
Coffee Break & Networking
13:00 – 14:20
13:00 – 14:20
Panel Session. The Future of Medicine Registration in the Eurasian Region
Unification of Registration Rules in the EAEU: Progress and Remaining Barriers
Uzbekistan's Experience in Aligning with EAEU Norms
Simplified Procedures for Innovative and Orphan Drugs
Pharmacopoeial Standards: Current Changes and Impact on Quality
Reducing Registration Timelines Through Unified Standards
The Impact of Regulatory Changes on Supply Chains
MIRBEK NYSHANBAEV
Head of the Department of Drug Registration, Department of Drugs and Medical Devices, Ministry of Health of the Republic of Kyrgyzstan
National Center for the Expertise of Medicines and Medical Devices
ELENA KOVALEVA
Director of the Center for Drug Quality Expertise, Scientific Center for Expertise of Medical Products of the Ministry of Health of the Russian Federation
14:20 – 15:20
14:20 – 15:20
Lunch Break
15:20 – 16:40
15:20 – 16:40
Panel Session. Pricing and Economic Efficiency in the Pharmaceutical Industry
Comparison of Pricing Models in the EAEU and CIS
Financing High-Cost Therapy: Mechanisms and Challenges
Reference Pricing: Country Selection and Complexities
Opportunities for a Unified Pricing Mechanism in the EAEU
Balancing the Interests of Patients, the State, and Business
Moderator: MARINA DURMANOVA
President, Association for the Support and Development of Pharmaceutical Activities of the Republic of Kazakhstan
LARISSA YEMELYANOVA
Partner, AEQUITAS Law Firm
ZAFAR VAKHIDOV
Partner, Vakhidov & Partners
Center for Expertise and Quality Control of Medical Care of the Ministry of Health of the Russian Federation
VICTORIA VYUSHKOVA
Director, Astellas Pharma
16:40 – 17:10
16:40 – 17:10
Coffee Break & Networking
17:10 – 18:30
17:10 – 18:30
Panel Session. Modern Models of Intellectual Property Protection and Management in the Pharmaceutical Industry
Patent Protection Strategies and Early Generic Entry
Compulsory Licensing and Legal Disputes in the EAEU
Specifics of Patenting Innovative Drugs
Parallel Import: Risks and Opportunities
Combating Counterfeits and Copies
Certificates of State Registration (CSR) for Dietary Supplements
Moderator: VADIM KUKAVA
Executive Director, Association of Pharmaceutical Companies "Pharmaceutical Innovations" ("InPharma")
ALEXANDER PANOV
Senior Partner, VERBA LEGAL
Agency for Protection and Development of Competition of the Republic of Kazakhstan
ALEXEY KARTASHOV
Director for Public Relations, HimRar Group
18:30
18:30
End of Day 1. Evening Reception and Informal Networking
Day 2, January 28
08:30 – 09:00
08:30 – 09:00
Morning Coffee & Networking
09:00 – 10:20
09:00 – 10:20
Expert Analytical Panel. Analysis of the EAEU Pharmaceutical Market: Key Trends, Challenges, and Growth Points
Sales Volumes and Segment Share (Generics, Innovative Drugs, and Biologics)
Market Growth Forecasts until 2027
Comparison with Global Trends
Impact of Inflation and Exchange Rate Fluctuations
Transformation of Consumer Preferences
Pharma Business Prospects for the Next 10 Years
EVGENIY ZEMLYANKIN
General Director, Amity International
NURZHAN OTARBAYEV
Chairman of the National Chamber of Health and the Committee on Pharmaceutical, Medical Industry, and Medical Services of Atameken
10:20 – 10:50
10:20 – 10:50
Coffee Break & Networking
10:50 – 12:10
10:50 – 12:10
Panel Session. National Pharmaceutical R&D Projects: Integrating Science, Production, and International Partnership
Search for New Molecules, Localization of Biopharmaceutical Production
Government Support: Funding, Certification, Procurement
Successful International Partnerships
Talent Retention and Development of Scientific Infrastructure
National Drug Security
Accelerated Scaling of Laboratory Technologies
12:10 – 12:40
12:10 – 12:40
Coffee Break & Networking
12:40 - 14:00
12:40 - 14:00
Panel Session. Commercialization of Pharmaceutical Products: Marketing and Digital Technologies
Online-Offline Integration in Marketing
Big Data and AI for Personalizing Communications
Digital Promotion Channels (E-commerce, Social Media, Mobile Apps)
Advertising Restrictions and Handling Personal Data
Sales Automation via CRM and Medical Representatives
Personalizing Interaction with Doctors and Pharmacies
LARISSA YEMELYANOVA
Partner, AEQUITAS Law Firm
14:00 - 15:00
14:00 - 15:00
Lunch Break
15:00 - 16:20
15:00 - 16:20
Panel Session. From Plant to Patient: Optimizing Pharmaceutical Product Supply in the New Reality
Transport Corridors and Logistics Solutions
Cold Chains and Customs Clearance
Problems and Solutions in Implementing Track & Trace
Digital Order Management Platforms
Interaction Between Manufacturers, Distributors, and Pharmacies
Combating Counterfeits Through Supply Chain Transparency
ZHAMILYA SHAIKHIBEKOVA
Head of the Investment Projects Department, SK-Pharmacy
ALEXANDRA TIKHONOVA
Head of Projects, Department of Socially Significant Goods, Center for the Development of Advanced Technologies (CDAT)
16:20 - 16:50
16:20 - 16:50
Coffee Break & Networking
16:50 – 18:00
16:50 – 18:00
Parallel sessions
Hall 1
How to Successfully Conduct Clinical Trials in EAEU Countries
Legislative Changes and National Requirements (borders with medicines)
Interaction with Medical Centers and Risk Management
Using AI in Data Analysis
GCP Inspections and Good Clinical Practice
Logistics of Clinical Trials
Labeling and Information Transparency
EKATERINA SOROKINA Director, Statandocs
Hall 2
The Dietary Supplements Market: New Consumer Trends and Growth Opportunities
Consumption Trends and Classification
Registration of Efficacy and Safety
Combating Falsification and the Uncontrolled Market
Growing Demand for Immunomodulators and Vitamins
Online Promotion Without Violations
Moderator: ALEXANDER ZHESTKOV Executive Director, Union of Dietary Supplement Manufacturers
ALEXEY PETRENKO Director of Global Projects, EAS Strategies
18:00
18:00
Discussion and Signing of the Resolution. Summarizing and Closing of the Forum. Cocktail Reception
CONTaCT US
CONTaCT US
CONTaCT US
CONTaCT US
CONTaCT US
CONTaCT US
For any questions regarding participation, partnership, or registration, please reach out to our team: